Brd4 Is Displaced from HPV Replication Factories as They Expand and Amplify Viral DNA

PLoS Pathogens

Volumn 9, Issue 11, 2013, Pages

  Sakakibara, Nozomi ^a,e   Chen, Dan ^a   Jang, Moon Kyoo ^a   Kang, Dong Wook ^b,f   Luecke, Hans F ^b   Wu, Shwu Yuan ^c,d   Chiang, Cheng Ming ^c,d   McBride, Alison A ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^f Catholic University of Daegu   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; BRD4 PROTEIN; E2 PROTEIN; GLYCOPROTEIN E1; GSK 525762A; GSK 525762A2; TRICHOSTATIN A; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

ARTICLE; AUTORADIOGRAPHY; CELL DIFFERENTIATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DNA REPAIR; DNA REPLICATION; DNA SYNTHESIS; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; SOUTHERN BLOTTING; VIROGENESIS; VIRUS GENOME; VIRUS REPLICATION; WART VIRUS; WESTERN BLOTTING;

CELL LINE; CHROMATIN; DNA REPLICATION; DNA, VIRAL; DNA-BINDING PROTEINS; GENOME, VIRAL; HUMAN PAPILLOMAVIRUS 16; HUMANS; NUCLEAR PROTEINS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; TRANSCRIPTION FACTORS; VIRUS REPLICATION;

EID: 84888234857     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003777     Document Type: Article

References (71)

1. Bedell MA, Hudson JB, Golub TR, Turyk ME, Hosken M, et al. (1991) Amplification of human papillomavirus genomes in vitro is dependent on epithelial differentiation. J Virol 65: 2254-2260.
2. McBride AA, Jang MK, (2013) Current understanding of the role of the Brd4 protein in the papillomavirus lifecycle. Viruses 5: 1374-1394.
3. Wu SY, Chiang CM, (2007) The double bromodomain-containing chromatin adaptor Brd4 and transcriptional regulation. J Biol Chem 282: 13141-13145.
4. Sakakibara N, Mitra R, McBride AA, (2011) The papillomavirus E1 helicase activates a cellular DNA damage response in viral replication foci. J Virol 85: 8981-8995.
5. Reinson T, Toots M, Kadaja M, Pipitch R, Allik M, et al. (2013) Engagement of the ATR-Dependent DNA Damage Response at the Human Papillomavirus 18 Replication Centers during the Initial Amplification. J Virol 87: 951-964.
6. Fradet-Turcotte A, Bergeron-Labrecque F, Moody CA, Lehoux M, Laimins LA, et al. (2011) Nuclear accumulation of the papillomavirus E1 helicase blocks S-phase progression and triggers an ATM-dependent DNA damage response. J Virol 85: 8996-9012.
7. Chaurushiya MS, Weitzman MD, (2009) Viral manipulation of DNA repair and cell cycle checkpoints. DNA Repair (Amst) 8: 1166-1176.
8. Sakakibara N, Chen D, McBride AA, (2013) Papillomaviruses use recombination-dependent replication to vegetatively amplify their genomes in differentiated cells. PLoS Pathog 9: e1003321.
9. Moody CA, Laimins LA, (2009) Human Papillomaviruses Activate the ATM DNA Damage Pathway for Viral Genome Amplification upon Differentiation. Plos Pathogens 5: e1000605.
10. Gillespie KA, Mehta KP, Laimins LA, Moody CA, (2012) Human papillomaviruses recruit cellular DNA repair and homologous recombination factors to viral replication centers. J Virol 86: 9520-9526.
11. You J, Croyle JL, Nishimura A, Ozato K, Howley PM, (2004) Interaction of the bovine papillomavirus E2 protein with Brd4 tethers the viral DNA to host mitotic chromosomes. Cell 117: 349-360.
12. Senechal H, Poirier GG, Coulombe B, Laimins LA, Archambault J, (2007) Amino acid substitutions that specifically impair the transcriptional activity of papillomavirus E2 affect binding to the long isoform of Brd4. Virology 358: 10-17.
13. Baxter MK, McPhillips MG, Ozato K, McBride AA, (2005) The mitotic chromosome binding activity of the papillomavirus E2 protein correlates with interaction with the cellular chromosomal protein, Brd4. J Virol 79: 4806-4818.
14. McPhillips MG, Oliveira JG, Spindler JE, Mitra R, McBride AA, (2006) Brd4 is required for e2-mediated transcriptional activation but not genome partitioning of all papillomaviruses. J Virol 80: 9530-9543.
15. Schweiger MR, You J, Howley PM, (2006) Bromodomain protein 4 mediates the papillomavirus e2 transcriptional activation function. J Virol 80: 4276-4285.
16. Lee AY, Chiang CM, (2009) Chromatin adaptor Brd4 modulates E2 transcription activity and protein stability. J Biol Chem 284: 2778-2786.
17. Muller M, Jacob Y, Jones L, Weiss A, Brino L, et al. (2012) Large scale genotype comparison of human papillomavirus E2-host interaction networks provides new insights for e2 molecular functions. PLoS Pathog 8: e1002761.
18. McPhillips MG, Ozato K, McBride AA, (2005) Interaction of bovine papillomavirus E2 protein with Brd4 stabilizes its association with chromatin. J Virol 79: 8920-8932.
19. Oliveira JG, Colf LA, McBride AA, (2006) Variations in the association of papillomavirus E2 proteins with mitotic chromosomes. Proc Natl Acad Sci U S A 103: 1047-1052.
20. McBride AA, Oliveira JG, McPhillips MG, (2006) Partitioning viral genomes in mitosis: same idea, different targets. Cell Cycle 5: 1499-1502.
21. Hummel M, Hudson JB, Laimins LA, (1992) Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes. J Virol 66: 6070-6080.
22. Meyers C, Frattini MG, Hudson JB, Laimins LA, (1992) Biosynthesis of human papillomavirus from a continuous cell line upon epithelial differentiation. Science 257: 971-973.
23. Ruesch MN, Stubenrauch F, Laimins LA, (1998) Activation of papillomavirus late gene transcription and genome amplification upon differentiation in semisolid medium is coincident with expression of involucrin and transglutaminase but not keratin-10. J Virol 72: 5016-5024.
24. Moody CA, Fradet-Turcotte A, Archambault J, Laimins LA, (2007) Human papillomaviruses activate caspases upon epithelial differentiation to induce viral genome amplification. Proc Natl Acad Sci U S A 104: 19541-19546.
25. Dey A, Chitsaz F, Abbasi A, Misteli T, Ozato K, (2003) The double bromodomain protein Brd4 binds to acetylated chromatin during interphase and mitosis. Proc Natl Acad Sci U S A 100: 8758-8763.
26. Heintzman ND, Stuart RK, Hon G, Fu Y, Ching CW, et al. (2007) Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat Genet 39: 311-318.
27. Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, et al. (2010) Selective inhibition of BET bromodomains. Nature 468: 1067-1073.
28. Nicodeme E, Jeffrey KL, Schaefer U, Beinke S, Dewell S, et al. (2010) Suppression of inflammation by a synthetic histone mimic. Nature 468: 1119-1123.
29. Norris KL, Lee JY, Yao TP, (2009) Acetylation goes global: the emergence of acetylation biology. Sci Signal 2: pe76.
30. Clayton AL, Hazzalin CA, Mahadevan LC, (2006) Enhanced histone acetylation and transcription: a dynamic perspective. Mol Cell 23: 289-296.
31. Wu SY, Lee AY, Hou SY, Kemper JK, Erdjument-Bromage H, et al. (2006) Brd4 links chromatin targeting to HPV transcriptional silencing. Genes Dev 20: 2383-2396.
32. Schweiger MR, Ottinger M, You J, Howley PM, (2007) Brd4 independent transcriptional repression function of the papillomavirus E2 proteins. J Virol 81: 9612-9622.
33. Stubenrauch F, Colbert AM, Laimins LA, (1998) Transactivation by the E2 protein of oncogenic human papillomavirus type 31 is not essential for early and late viral functions. J Virol 72: 8115-8123.
34. Jeon S, Allenhoffmann BL, Lambert PF, (1995) Integration of Human Papillomavirus Type-16 into the Human Genome Correlates with a Selective Growth Advantage of Cells. Journal of Virology 69: 2989-2997.
35. Jang MK, Kwon D, McBride AA, (2009) Papillomavirus E2 proteins and the host BRD4 protein associate with transcriptionally active cellular chromatin. J Virol 83: 2592-2600.
36. Fradet-Turcotte A, Moody C, Laimins LA, Archambault J, (2010) Nuclear export of human papillomavirus type 31 E1 is regulated by Cdk2 phosphorylation and required for viral genome maintenance. J Virol 84: 11747-11760.
37. Nakahara T, Peh WL, Doorbar J, Lee D, Lambert PF, (2005) Human papillomavirus type 16 E1∧E4 contributes to multiple facets of the papillomavirus life cycle. J Virol 79: 13150-13165.
38. Banerjee NS, Wang HK, Broker TR, Chow LT, (2011) Human papillomavirus (HPV) E7 induces prolonged G2 following S phase reentry in differentiated human keratinocytes. J Biol Chem 286: 15473-15482.
39. Floyd SR, Pacold ME, Huang Q, Clarke SM, Lam FC, et al. (2013) The bromodomain protein Brd4 insulates chromatin from DNA damage signalling. Nature 498: 246-250.
40. Choi S, Bakkenist CJ, (2013) Brd4 Shields Chromatin from ATM Kinase Signaling Storms. Sci Signal 6: pe30.
41. Smith PP, Friedman CL, Bryant EM, McDougall JK, (1992) Viral integration and fragile sites in human papillomavirus-immortalized human keratinocyte cell lines. Genes, chromosomes & cancer 5: 150-157.
42. Letessier A, Millot GA, Koundrioukoff S, Lachages AM, Vogt N, et al. (2011) Cell-type-specific replication initiation programs set fragility of the FRA3B fragile site. Nature 470: 120-123.
43. Alderborn A, Jareborg N, Burnett S, (1992) Evidence that the transcriptional trans-activating function of the bovine papillomavirus type 1 E2 gene is not required for viral DNA amplification in division-arrested cells. J Gen Virol 73: 2639-2651.
44. Sakai H, Yasugi T, Benson JD, Dowhanick JJ, Howley PM, (1996) Targeted mutagenesis of the human papillomavirus type 16 E2 transactivation domain reveals separable transcriptional activation and DNA replication functions. J Virol 70: 1602-1611.
45. Abroi A, Kurg R, Ustav M, (1996) Transcriptional and replicational activation functions in the BPV1 E2 protein are encoded by different structural determinants. J Virol 70: 6169-6179.
46. Ilves I, Maemets K, Silla T, Janikson K, Ustav M, (2006) Brd4 is involved in multiple processes of the bovine papillomavirus type 1 life cycle. J Virol 80: 3660-3665.
47. Ilves I, Kivi S, Ustav M, (1999) Long-term episomal maintenance of bovine papillomavirus type 1 plasmids is determined by attachment to host chromosomes, which is mediated by the viral E2 protein and its binding sites. Journal of Virology 73: 4404-4412.
48. Abbate EA, Berger JM, Botchan MR, (2004) The X-ray structure of the papillomavirus helicase in complex with its molecular matchmaker E2. Genes Dev 18: 1981-1996.
49. Abbate EA, Voitenleitner C, Botchan MR, (2006) Structure of the papillomavirus DNA-tethering complex E2:Brd4 and a peptide that ablates HPV chromosomal association. Mol Cell 24: 877-889.
50. Wu SY, Lee AY, Lai HT, Zhang H, Chiang CM, (2013) Phospho switch triggers brd4 chromatin binding and activator recruitment for gene-specific targeting. Mol Cell 49: 843-857.
51. Wang X, Li J, Schowalter RM, Jiao J, Buck CB, et al. (2012) Bromodomain Protein Brd4 Plays a Key Role in Merkel Cell Polyomavirus DNA Replication. PLoS pathogens 8: e1003021.
52. Zhao R, Nakamura T, Fu Y, Lazar Z, Spector DL, (2011) Gene bookmarking accelerates the kinetics of post-mitotic transcriptional re-activation. Nat Cell Biol 13: 1295-1304.
53. Ferrari R, Berk AJ, Kurdistani SK, (2009) Viral manipulation of the host epigenome for oncogenic transformation. Nat Rev Genet 10: 290-294.
54. Flores ER, Lambert PF, (1997) Evidence for a switch in the mode of human papillomavirus type 16 DNA replication during the viral life cycle. J Virol 71: 7167-7179.
55. Thomas JT, Hubert WG, Ruesch MN, Laimins LA, (1999) Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes. Proc Natl Acad Sci U S A 96: 8449-8454.
56. Park RB, Androphy EJ, (2002) Genetic analysis of high-risk e6 in episomal maintenance of human papillomavirus genomes in primary human keratinocytes. J Virol 76: 11359-11364.
57. Oh ST, Longworth MS, Laimins LA, (2004) Roles of the E6 and E7 proteins in the life cycle of low-risk human papillomavirus type 11. J Virol 78: 2620-2626.
58. Hong S, Laimins LA, (2013) The JAK-STAT Transcriptional Regulator, STAT-5, Activates the ATM DNA Damage Pathway to Induce HPV 31 Genome Amplification upon Epithelial Differentiation. PLoS pathogens 9: e1003295.
59. Bester AC, Roniger M, Oren YS, Im MM, Sarni D, et al. (2011) Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell 145: 435-446.
60. Wang X, Helfer CM, Pancholi N, Bradner JE, You J, (2013) Recruitment of brd4 to the human papillomavirus type 16 DNA replication complex is essential for replication of viral DNA. J Virol 87: 3871-3884.
61. Maruyama T, Farina A, Dey A, Cheong J, Bermudez VP, et al. (2002) A Mammalian bromodomain protein, Brd4, interacts with replication factor C and inhibits progression to S phase. Mol Cell Biol 22: 6509-6520.
62. Rahman S, Sowa ME, Ottinger M, Smith JA, Shi Y, et al. (2011) The Brd4 extraterminal domain confers transcription activation independent of pTEFb by recruiting multiple proteins, including NSD3. Mol Cell Biol 31: 2641-2652.
63. Van Doorslaer K, Tan Q, Xirasagar S, Bandaru S, Gopalan V, et al. (2013) The Papillomavirus Episteme: a central resource for papillomavirus sequence data and analysis. Nucleic Acids Res 41: D571-578.
64. Dowhanick JJ, McBride AA, Howley PM, (1995) Suppression of cellular proliferation by the papillomavirus E2 protein. J Virol 69: 7791-7799.
65. Thierry F, Yaniv M, (1987) The BPV1-E2 trans-acting protein can be either an activator or a repressor of the HPV18 regulatory region. EMBO J 6: 3391-3397.
66. Smith JA, White EA, Sowa ME, Powell ML, Ottinger M, et al. (2010) Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression. Proc Natl Acad Sci U S A 107: 3752-3757.
67. Evans MF, Aliesky HA, Cooper K, (2003) Optimization of biotinyl-tyramide-based in situ hybridization for sensitive background-free applications on formalin-fixed, paraffin-embedded tissue specimens. BMC Clin Pathol 3: 2.
68. Del Vecchio AM, Romanczuk H, Howley PM, Baker CC, (1992) Transient replication of human papillomavirus DNAs. J Virol 66: 5949-5958.
69. Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, et al. (1984) A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J 3: 1151-1157.
70. Chapman S, Liu X, Meyers C, Schlegel R, McBride AA, (2010) Human keratinocytes are efficiently immortalized by a Rho kinase inhibitor. J Clin Invest 120: 2619-2626.
71. Gosmini RLM, Mirguet O (2011) Benzodiazepine Bromodomain Inhibitor. WO Patent 2,011,054,553.